Honasa Consumer Q1 FY27 Earnings Call — Analysis (NSE: HONASA)
Honasa Consumer reports 32% revenue growth with EBITDA of ₹110 Cr and PAT of ₹90 Cr, driven by volume, focus categories, and offline expansion.
Result quality: strong — Margin expansion. Management sentiment: optimistic.
The take
Q1FY27 Revenue Growth 32% . New guidance — FY31 honasa consolidated revenue cagr high-teens . New story: Offline expansion bearing fruit .
Results
Revenue growth 32% YoY; EBITDA ₹110 Cr; PAT ₹90 Cr; volume growth 30.5%; cash generation ₹83 Cr; normalized EBITDA margin ~12.5%.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue Growth | 32% | yoy · Q1FY27 | |
| EBITDA | ₹110 Cr | yoy · Q1FY27 | |
| PAT | ₹90 Cr | yoy · Q1FY27 | |
| Volume Growth | 30.5% | yoy · Q1FY27 | |
| Cash Generation | ₹83 Cr | yoy · Q1FY27 | |
| Normalized EBITDA Margin | ~12.5% | yoy · Q1FY27 · adjusted for one-time opex benefit | |
| GT Secondary Sales Growth | 40%+ | yoy · Q1FY27 | |
| MT Offtake Growth | 40%+ | yoy · Q1FY27 | |
| E-commerce Growth | 20%+ | yoy · Q1FY27 |
Guidance
FY27 revenue growth seen above long-term high-teens CAGR; full-year EBITDA margin improvement of at least 150-200 bps over FY26.
What management committed to
- Honasa will deliver a high-teens revenue CAGR over the next five years. — high-teens, FY31
- FY27 revenue growth will be better than the high-teens CAGR. — better than high-teens CAGR, FY27
- EBITDA margin will expand by 100-150 bps each year to reach ~15% in five years. — 15% EBITDA margin, FY31
- FY27 full-year EBITDA margin improvement will be at least 150-200 bps over FY26. — at least 150-200 bps, FY27
- Mamaearth will remain a double-digit CAGR growth story over the next five years. — double-digit CAGR, FY31
- Mamaearth FY27 growth will be better than the planned double-digit CAGR. — better than planned double-digit CAGR, FY27
- Rice franchise under Mamaearth can become a ₹500 Cr franchise. — ₹500 Cr
- Rosemary shampoo can become a ₹250 Cr franchise next year. — ₹250 Cr, FY28
- [Mamaearth] Tea Tree Face Wash (acne) and Lemon & Aloe Shampoo (dandruff) will become ₹100 Cr franchises over the next two to three years. — ₹100 Cr, FY30
- Honasa will sharpen the proposition positioning of Aqualogica, Dr. Sheth’s, and BBlunt over the next 6-9 months. — Q4FY27
- Honasa will continue to look at inorganic opportunities in nutrition and wellness to bolster capabilities.
Key themes
Broad-based growth, margin expansion, fragrance entry
How the narrative shifted
- Fragrance as horizon two category: Management presents fragrances as a large, under-penetrated, premiumising category in India, entering it with a differentiated elixir-based brand FIKN after 1.5 years of R&D, drawing global BPC parallels.
- Offline expansion bearing fruit: Redesigned distribution system, high-quality distributors, disciplined inventory management (<30 days) drive 40%+ GT and MT growth with market share gains, proving the offline playbook.
- Core brand Mamaearth re-acceleration: Mamaearth high-teens growth driven by hero SKUs and focus categories, with brand health metrics (searches, brand power) at all-time highs, demonstrating the large brand playbook.
- Young brands scaling & margin improvement: Young brands grow 30%+; The Derma Co hits ₹1,000 Cr ARR and teens EBITDA; Aqualogica restaged; portfolio moving towards multiple large, profitable brands.
- Margin expansion with growth reinvestment: Gross margin benefits from channel mix and scale are being partly reinvested to fuel growth, with the commitment to gradually expand EBITDA margins 100-150 bps/year toward 15%.
- Acquisition-led growth capability: BTM Ventures doubled since acquisition; Fluence (nutraceuticals) under process; management signals M&A as a repeatable growth lever across beauty and wellness.
- Premiumisation and consumer upgrade in beauty: Indian consumers are shifting from deodorants to fine fragrances and towards branded, efficacy-led products; e-commerce and quick commerce accelerate this trend.
Operational commentary
- Focus categories (face wash, sunscreen, etc.) grew over 35%, now contributing ~85% of revenue.
- Mamaearth accelerated to high teens growth led by hero SKUs: Rice Face Wash, Ubtan, Rosemary shampoo (₹100 Cr+ ARR ingredient), Sun Care.
- The Derma Co reached ₹1,000 Cr+ ARR, entered teens EBITDA club, gaining traction offline (50,000 stores, 20% offline mix).
- Young brands (excl. BTM Ventures) grew 30%+; Aqualogica restaged for Gen Z, Reginald, Dr. Sheth’s, BBlunt, Staze all scaling.
- BTM Ventures acquisition grew ~100% since Jan’26 to ₹150 Cr ARR, expanded to Maharashtra, new category, new channels.
- Offline expansion delivered 40%+ GT secondary sales growth and 40%+ MT offtakes; distribution footprint reached 3 lakh outlets (Nielsen).
- Market share gains: +350 bps in face washes, +160 bps in shampoos in offline.
- Launched FIKN, India’s first elixir-based fragrance brand with patented design and clinically tested 12-hour longevity, entering the premium fragrance category.
- Distribution system restructured: direct distribution focused on 100 cities, distributor inventory <30 days, healthy retail STRs.
- E-commerce grew 20%+, with share gains in quick commerce on branded search strength.
- Honasa Health subsidiary created for nutraceuticals; Fluence Pharma acquisition under condition precedent; organic R&D capabilities being built.
Analyst Q&A
Q. Expectation for revenue growth over the rest of the year given higher base in coming quarters?
We have a five-year high-teens CAGR agenda. This year will be better than that CAGR on growth profile. Priority remains reinvesting to grow faster, sticking to five-year callout.
Q. How do you ensure market share gain on quick commerce when number of brands is expanding daily?
Quick commerce is a further branded purchase play in our category; as long as our brands get stronger, we will gain share. Pareto will thrive in constrained physical space format.
Q. Given you are already at 12.5% normalized EBITDA margin, how do you balance growth investments vs margin expansion?
The plan shared at Investor Day prioritises growth over margin. It already accounts for new categories/brands. Core will become more profitable, funding new bets while still meeting the margin improvement commitment.
Q. Impact of higher packaging/logistics costs seen by peers not visible in Honasa’s numbers; how was this managed?
Good inventory management in Q1 avoided impact; real impact expected in Q2. but calibrated price increases taken towards end of Q1 will offset inflationary pressure on gross margin.
Q. 1Q EBITDA appears unusually high even after adjusting one-time items; is the margin guidance too conservative?
Q1 benefited from seasonal leverage. Focus remains growth first; we will reinvest if opportunities arise. For full year, we target 100-150 bps margin improvement, but this year we may do 150-200 bps.
Research and educational content only. Not investment advice.